# NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS)

NewAmsterdam Pharma announces Young Researcher Award winners, highlighting commitment to advancing lipid biology and cardiovascular disease research. Company also shares insights on the evolving landscape of lipid-lowering therapies.

### About NewAmsterdam Pharma Company N.V. Ordinary Shares
NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) is a stock in the healthcare sector.  
NewAmsterdam Pharma Company N.V. Ordinary Shares uses the ticker $NAMS for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) trading volume is up 46.84% from the previous week.
- NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) social dominance is up 309.09% from the previous week.
- NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) Galaxy Score™ is up 41.67% from the previous week.
- NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) engagements is up 26.22% from the previous week.

### Price: $34.60
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$nams/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$nams/time-series/close.tsv)  
The stock is trading near its 52-week high, driven by acquisition rumors and positive market sentiment. A recent minor dip is likely due to profit-taking after the upward trend.  

24-Hour: -0.09%
7-Day: 0.96%
30-Day: 9.42%

1-Year High: $41.50 on 2025-11-26  
1-Year Low: $14.90 on 2025-04-10  
  
  
### AltRank: [---]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$nams/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$nams/time-series/alt_rank.tsv)  
NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) is currently AltRank #505 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [-----] +894  
[--] Month: [-----] +198  
[--] Months: [-----] +945  
[--] Year: [-----] +306  
1-Year High: [-----] on 2026-02-07  
1-Year Low: [--] on 2025-10-12  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$nams/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$nams/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +10  
[--] Month: [--] +8  
1-Year High: [--] on 2025-12-19  
1-Year Low: [--] on 2025-12-24  
  
  
### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$nams/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$nams/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [-----]  
[--] Week: [------] +26%  
[--] Month: [------] -79%  
[--] Months: [---------] +39%  
[--] Year: [---------] +37%  
1-Year High: [------] on 2025-12-22  
1-Year Low: [--] on 2025-04-24  

Engagements by network (24h):
News: [--]
X: [-----]
Reddit: [--]
YouTube: [--]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$nams/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$nams/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [---] -25%  
[--] Month: [---] +16%  
[--] Months: [-----] +4.80%  
[--] Year: [-----] +146%  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2025-04-28  

Mentions by network (24h):
News: [--]
X: [--]
Reddit: [--]
YouTube: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$nams/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$nams/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) in the last [--] hours which is up 4.60% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [--] -44%  
[--] Month: [---] +49%  
[--] Months: [---] -47%  
[--] Year: [-----] +146%  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2025-04-28  

The most influential creators that mention NewAmsterdam Pharma Company N.V. Ordinary Shares in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@NewAmsPharma](/creator/twitter/NewAmsPharma)       | [--]    | [-----]     | [--]     | [-----]       |
| [@BuyTheUgly](/creator/twitter/BuyTheUgly)           | [--]    | [--]        | [--]    | [---]         |
| [@seedy19tron](/creator/twitter/seedy19tron)         | [--]    | [------]    | [--]     | [--]          |
| [@stocket_rocket](/creator/twitter/stocket_rocket)   | [--]    | [--]        | [--]     | [--]          |
| [@Biotech2k1](/creator/twitter/Biotech2k1)           | [--]    | [------]    | [--]     | [--]          |
| [@mariostario2019](/creator/twitter/mariostario2019) | [--]    | [--]        | [--]     | [--]          |
| [@BoutiqueBiotech](/creator/twitter/BoutiqueBiotech) | [--]    | [---]       | [--]     | [--]          |
| [@StockTickerZone](/creator/twitter/StockTickerZone) | [--]    | [-----]     | [--]    | [--]          |
| [@oratnek_ill](/creator/twitter/oratnek_ill)         | [--]    | [-----]     | [--]     | [--]           |

[View More](/list/creators/$nams/100)
  
  
### Sentiment: 80%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$nams/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$nams/time-series/sentiment.tsv)  
Current Value: 80%  
Daily Average: 85%  
[--] Week: 50% no change  
[--] Month: 50% -17%  
[--] Months: 50% -46%  
[--] Year: 50% -40%  
1-Year High: 100% on 2025-02-19  
1-Year Low: 29% on 2025-09-24  

Most Supportive Themes:
- Acquisition Rumors: (50%) Speculation about potential acquisition news is driving positive market sentiment.
- Positive Market Sentiment: (30%) The stock is trading near its 52-week high, supported by overall positive market sentiment.
  
Most Critical Themes:
- Recent Price Dip: (20%) Despite overall resilience, the stock experienced a slight dip in the last [--] hours.
  
  
  
### Social Dominance: 0.00501%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$nams/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$nams/time-series/social_dominance.tsv)  
Current Value: 0.00501%  
Daily Average: 0.00568%  
[--] Week: 0.0045% +0.0034%  
[--] Month: 0.0059% +0.0023%  
[--] Months: 0.0059% -0.00010000000000000026%  
[--] Year: 0.0059% +0.0025%  
1-Year High: 0.031% on 2025-06-29  
1-Year Low: 0.0012% on 2025-04-28  
  
  
### Market Dominance: 0.00445%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$nams/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$nams/time-series/market_dominance.tsv)  
Current Value: 0.00445%  
Daily Average: 0%  
1-Year High: 0.18% on 2026-02-06  
1-Year Low: 0.00445% on 2026-02-13  
  
  
### Market Cap: $3,926,723,543
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$nams/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$nams/time-series/market_cap.tsv)  
Current Value: $3,926,723,543  
Daily Average: $3,785,930,046  
[--] Week: $3,926,723,543 +0.96%  
[--] Month: $3,926,723,543 +8.80%  
1-Year High: $4,700,048,826 on 2025-11-26  
1-Year Low: $2,697,451,569 on 2025-08-28  

### Top NewAmsterdam Pharma Company N.V. Ordinary Shares Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"Nearly [--] years ago statins reshaped lipid management. Since then additional therapies have expanded treatment options but many patients still do not reach recommended LDL-C goals. As we enter the next era of lipid-lowering therapy there is a meaningful opportunity to provide solutions that are effective well-tolerated and easier for patients and providers to manage helping more people achieve LDL-C levels associated with better cardiovascular health. Learn more about evolving treatment considerations and what patients and clinicians can expect next: https://www.expectmoreforldl.com/"  
[X Link](https://x.com/NewAmsPharma/status/2021970555101229136) [@NewAmsPharma](/creator/x/NewAmsPharma) 2026-02-12T15:32Z [----] followers, 10.7K engagements


"Congratulations to Drs. @AllisonWPeng and @aarti693 on receivingNewAmsterdam Pharma'sYoung Researcher Award (YRA)a program supporting early-career investigators advancing innovative research in lipid biology cardiovascular disease and related metabolic conditions. Dr. Peng isa cardiovascular diseasefellow at the Johns Hopkins @CiccaroneCenter whose research focuses on cardiovascular prevention and imaging applying AI and large datasets to improve risk assessment and early detection of ASCVD. She earned her engineering degree from Columbia University and completedherinternal medicine residency"  
[X Link](https://x.com/NewAmsPharma/status/2020914934339813480) [@NewAmsPharma](/creator/x/NewAmsPharma) 2026-02-09T17:37Z [----] followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing